Abstract:Uncovering the stimulus-response histories that give rise to cell fates and behaviors is an area of great interest in developmental biology, tissue engineering, and regenerative medicine. A comprehensive accounting of cell experiences that lead to the development of organs and tissues can help us to understand developmental anomalies that may underly disease. Perhaps more provocatively, such a record can also reveal clues as to how to drive cell collective decision-making processes, which may yield predictable cell-based therapies or facilitate production of tissue substitutes for transplantation or in vitro screening of prospective therapies to mitigate disease. Toward this end, various methods have been applied to molecularly trace developmental trajectories and record interaction histories of cells. Typical methods involve artificial gene circuits based on recombinases that activate a suite of fluorescent reporters or CRISPR-Cas9 genome writing technologies whose nucleic acid-based record keeping serves to chronicle cell-cell interactions or past exposure to stimuli of interests. Exciting expansions of the synthetic biology toolkit with artificial receptors that permit establishment of defined input-to-output linkages of cell decision-making processes opens the door to not only record cell-cell interactions, but to also potentiate directed manipulation of the outcomes of such interactions via regulation of carefully selected transgenes. Here, we combine CRISPR-based strategies to genetically and epigenetically manipulate cells to express components of the synthetic Notch receptor platform, a widely used artificial cell signaling module. Our approach gives rise to the ability to conditionally record interactions between human cells, where the record of engagement depends on expression of a state-specific marker of a subset of cells in a population. Further, such signal-competent interactions can be used to direct differentiation of human embryonic stem cells toward pre-selected fates based on assigned synNotch outputs. We also implemented CRISPR-based manipulation of native gene expression profiles to bias outcomes of cell engagement histories in a targeted manner. Thus, we present a useful strategy that gives rise to both state-specific recording of cell-cell interactions as well as methods to intentionally influence products of such cell-cell exchanges.

Dynamically Reshaping Signaling Networks to Program Cell Fate via Genetic Controllers

Engineering Mouse Cell Fate Controller by Rational Design

Synthesizing Artificial Devices That Redirect Cellular Information at Will

Peptide-Dependent Growth in Yeast via Fine-Tuned Peptide/GPCR-Activated Essential Gene Expression

Clinically-driven design of synthetic gene regulatory programs in human cells

Cellular checkpoint control using programmable sequential logic

Multifunctional Systems in Synthetic Biology: Single-Stranded DNA Signaling for Precise Control of Gene Activation

Reprogramming cell fates by small molecules

[Signaling Network-Based Functional Cell Design].

Exploiting protein domain modularity to enable synthetic control of engineered cells

Controlling Synthetic Cell-Cell Communication

Optimising Boolean Synthetic Regulatory Networks to Control Cell States

Synthetic Biology Applications of the Yeast Mating Signal Pathway.

Rewiring of endogenous signaling pathways to genomic targets for therapeutic cell reprogramming

Engineering eukaryote-like regulatory circuits to expand artificial control mechanisms for metabolic engineering in Saccharomyces cerevisiae

Use of CRISPRoff and synthetic Notch to modulate and relay endogenous gene expression programs in engineered cells

Perspectives on Synthetic Protein Circuits in Mammalian Cells

Small molecule and cell contact-inducible systems for controlling expression and differentiation in stem cells

Small molecules in cellular reprogramming and differentiation.

Designing cell function: assembly of synthetic gene circuits for cell biology applications

Engineering combinatorial and dynamic decoders using synthetic immediate-early genes